| Cat. No. |
产品名 |
作用方式
|
纯度 |
是否罕见病
|
| HY-W040193 |
DSPC |
|
99.95% |
否 |
| HY-12364 |
C75 |
Inhibitor |
99.91% |
否 |
| HY-130462 |
1-Palmitoyl-2-oleoyl-sn-glycero-3-PC |
|
99.98% |
否 |
| HY-N0615 |
Notoginsenoside R1 |
Inhibitor |
99.93% |
否 |
| HY-70072 |
D609 |
Inhibitor |
≥98.0% |
否 |
| HY-P1028 |
Hexa-D-arginine |
|
99.85% |
否 |
| HY-113123 |
LysoPC(14:0/0:0) |
|
99.84% |
否 |
| HY-N9410 |
Lysophosphatidylcholine 18:2 |
|
99.12% |
否 |
| HY-130709 |
PROTAC CDK2/9 Degrader-1 |
Inhibitor |
99.85% |
否 |
| HY-14307 |
Necrocide 1 |
Inducer |
98.84% |
否 |
| HY-153910 |
AGPS-IN-1 |
|
99.74% |
否 |
| HY-113253A |
N8-Acetylspermidine dihydrochloride |
|
≥98.0% |
否 |
| HY-125771 |
1-Stearoyl-sn-glycero-3-phosphocholine |
|
99.53% |
否 |
| HY-100014 |
KDM5A-IN-1 |
Inhibitor |
99.64% |
否 |
| HY-108361 |
CCG-203971 |
Inhibitor |
99.89% |
否 |
| HY-142684 |
Pyruvate Carboxylase-IN-1 |
Inhibitor |
99.43% |
否 |
| HY-D1025 |
C-Phycocyanin |
|
/ |
否 |
| HY-Y1667 |
2,6-Dibromophenol |
Inhibitor |
99.76% |
否 |
| HY-124042 |
K6PC-5 |
|
99.27% |
否 |
| HY-101392 |
Harmane |
Inhibitor |
99.91% |
否 |
| HY-149433 |
BWA-522 |
Inducer |
99.93% |
否 |
| HY-N3544 |
Caryophyllene oxide |
|
99.71% |
否 |
| HY-N1353 |
Rhamnocitrin |
Inhibitor |
99.67% |
否 |
| HY-126726 |
KOdiA-PC |
|
99.00% |
否 |
| HY-158790 |
(R)-HTS-3 |
Inhibitor |
99.29% |
否 |
| HY-101947 |
SMI-16a |
Inhibitor |
≥98.0% |
否 |
| HY-146985 |
Cathepsin X-IN-1 |
Inhibitor |
99.62% |
否 |
| HY-16160 |
Cysmethynil |
|
99.87% |
否 |
| HY-B0927 |
Hydrastine |
Inhibitor |
99.57% |
否 |
| HY-157544 |
PC5-VC-PAB-MMAE |
Inhibitor |
99.76% |
否 |
| HY-133968 |
24-Methylenecholesterol |
|
99.48% |
否 |
| HY-W748591 |
Cannflavin A |
|
99.20% |
否 |
| HY-156041 |
Lysophosphatidylethanolamines, egg |
|
≥99.0% |
否 |
| HY-138555 |
PROTAC BRD4 Degrader-8 |
Inhibitor |
99.45% |
否 |
| HY-138622 |
24:0 Lyso PC |
Chemical |
99.70% |
否 |
| HY-143202 |
DPhPC |
|
99.68% |
否 |
| HY-132197 |
CBP/p300-IN-12 |
Inhibitor |
99.72% |
否 |
| HY-110166 |
PD 90780 |
|
≥99.0% |
否 |
| HY-107416 |
RHC 80267 |
Inhibitor |
99.41% |
否 |
| HY-140132 |
PC Biotin-PEG3-azide |
|
97.75% |
否 |
| HY-W322575 |
1,2-Diheptadecanoyl-sn-glycero-3-phosphorylcholine |
|
≥99.0% |
否 |
| HY-W440983 |
SDPC |
Activator |
≥98.0% |
否 |
| HY-142990 |
1-Oleoyl-2-palmitoyl-sn-glycero-3-PC |
|
99.80% |
否 |
| HY-N6601 |
Pomolic acid |
Inducer |
98.14% |
否 |
| HY-W329357 |
15:0 Lyso PC |
|
99.6% |
否 |
| HY-W440982 |
SOPC |
|
≥98.0% |
否 |
| HY-W704966 |
2-Stearoyl-sn-glycero-3-phosphocholine |
|
≥95.0% |
否 |
| HY-12842 |
UC-112 |
|
98.92% |
否 |
| HY-157698 |
1-1(Z)-Octadecenyl-2-arachidonoyl-sn-glycero-3-PC |
|
≥99.0% |
否 |
| HY-102067 |
3289-8625 |
Inhibitor |
/ |
否 |
| HY-119257 |
ABT-100 |
|
98.18% |
否 |
| HY-146331 |
PC190723 |
Inhibitor |
98.34% |
否 |
| HY-146879S |
26:0 Lyso PC-d4 |
|
95.60% |
否 |
| HY-149091 |
KDM5B-IN-4 |
Inhibitor |
99.68% |
否 |
| HY-171616 |
DCEM1 |
Inhibitor |
98.00% |
否 |
| HY-N4285 |
Negletein |
Inhibitor |
99.55% |
否 |
| HY-141636 |
1-PalMitoyl-2-arachidoyllecithin |
|
≥99.0% |
否 |
| HY-W040193A |
DSPC (Excipient, GMP Like) |
|
99.93% |
否 |
| HY-138635 |
PROTAC BRD4 Degrader-12 |
Inhibitor |
98.54% |
否 |
| HY-150023 |
BI-1622 |
Inhibitor |
98.97% |
否 |
| HY-108016 |
Peruvoside |
|
99.32% |
否 |
| HY-122678 |
LQZ-7F |
|
97.13% |
否 |
| HY-126359 |
1-Stearoyl-2-linoleoyl-sn-glycero-3-phosphocholine |
|
≥98.0% |
否 |
| HY-130462S |
1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-d31 |
|
≥99.0% |
否 |
| HY-140134 |
PC Biotin-PEG3-NHS ester |
|
≥95.0% |
否 |
| HY-147696 |
SMTIN-T140 |
|
99.58% |
否 |
| HY-N8303 |
Gardenin A |
|
97.61% |
否 |
| HY-P1831 |
Proadrenomedullin (1-20), human |
Modulator |
99.71% |
否 |
| HY-W040193S |
1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d70 |
|
≥99.0% |
否 |
| HY-113123S1 |
LysoPC(14:0/0:0)-d7 |
|
95.4% |
否 |
| HY-121522 |
SD-70 |
Inhibitor |
99.20% |
否 |
| HY-140140 |
PC Mal-NHS carbonate ester |
|
≥95.0% |
否 |
| HY-153754 |
Phosphatidylcholine transfer protein inhibitor-1 |
|
98.01% |
否 |
| HY-153901 |
PROTAC EGFR degrader 8 |
Inhibitor |
98.90% |
否 |
| HY-P1028A |
Hexa-D-arginine TFA |
|
98.42% |
否 |
| HY-P3320 |
Phytochelatin 3 |
|
99.34% |
否 |
| HY-156778 |
Antitumor agent-120 |
|
≥96.0% |
否 |
| HY-157700 |
Hexadecenyl-2-hydroxy-sn-glycero-3-PC |
|
99.40% |
否 |
| HY-165997 |
1-1(Z)-Hexadecenyl-2-Palmitoyl-sn-glycero-3-PC |
|
97.1% |
否 |
| HY-105118A |
Zaldaride maleate |
Antagonist |
99.7% |
否 |
| HY-140138 |
PC SPDP-NHS carbonate ester |
|
≥95.0% |
否 |
| HY-140139 |
PC Alkyne-PEG4-NHS ester |
|
≥95.0% |
否 |
| HY-142988 |
1-Stearoyl-2-myristoyl-sn-glycero-3-PC |
|
≥98.0% |
否 |
| HY-146895S |
14:0 Lyso PC-d27 |
|
≥99.0% |
否 |
| HY-N5021 |
Anhydrosafflor yellow B |
|
85.30% |
否 |
| HY-P5754B |
TAT-NEP1-40 acetate |
Inhibitor |
94.33% |
否 |
| HY-RS11190 |
PROC Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
否 |
| HY-W019833 |
MSPC |
|
≥99.0% |
否 |
| HY-131652 |
1,2-Di-O-hexadecyl-sn-glycero-3-phosphocholine |
|
97.0% |
否 |
| HY-139931S |
1-Stearoyl-2-Arachidonoyl-d8-sn-glycero-3-PC |
|
≥99.0% |
否 |
| HY-150135B |
D-myo-Inositol 1,4,5-trisphosphate tripotassium |
Activator |
98.00% |
否 |
| HY-153725 |
17:1 Lyso PC |
|
≥98.0% |
否 |
| HY-157423 |
16:1 (DELTA 9-Cis) PC |
|
≥99.0% |
否 |
| HY-70083 |
SPK-601 |
Inhibitor |
98.46% |
否 |
| HY-W020809 |
C18(Plasm) LPC |
|
≥99.0% |
否 |
| HY-138634 |
PROTAC BRD4 Degrader-11 |
Inhibitor |
99.45% |
否 |
| HY-138632 |
PROTAC BRD4 Degrader-9 |
Inhibitor |
98.23% |
否 |
| HY-103385 |
NCX4040 |
Inducer |
99.82% |
否 |
| HY-108508 |
SMANT hydrochloride |
Inhibitor |
99.90% |
否 |
| HY-110260 |
LDN-193188 |
|
99.69% |
否 |
| HY-125172 |
PolyQ aggregation inhibitor C2-8 |
Inhibitor |
/ |
否 |
| HY-128536 |
KMG-104AM |
|
/ |
否 |
| HY-131640 |
1,2-Didecanoyl PC |
|
≥98.0% |
否 |
| HY-136704 |
GLS1 Inhibitor-1 |
Inhibitor |
98.5% |
否 |
| HY-138622S1 |
24:0 Lyso PC-d4 |
|
≥95.0% |
否 |
| HY-138756 |
PC DBCO-PEG4-NHS ester |
|
96.85% |
否 |
| HY-140142 |
PC Azido-PEG11-NHS carbonate ester |
|
90.42% |
否 |
| HY-146840S |
17:0-14:1 PC-d5 |
|
≥99.0% |
否 |
| HY-147100 |
α1A-AR Degrader 9c |
Inhibitor |
99.60% |
否 |
| HY-149149 |
Incadronic acid |
Inhibitor |
98.03% |
否 |
| HY-157413 |
YS-67 |
Inhibitor |
99.41% |
否 |
| HY-158310 |
SOS1/EGFR-IN-1 |
Inhibitor |
99.54% |
否 |
| HY-163683 |
EB-PSMA-617 |
Inhibitor |
96.38% |
否 |
| HY-165029 |
1-Palmitoyl-2-linoleoyl-sn-glycero-3-PC |
|
≥99.0% |
否 |
| HY-N11001 |
Erinacine U |
|
99.54% |
否 |
| HY-N4192 |
Toringin |
|
99.62% |
否 |
| HY-N7972 |
19-Oxocinobufotalin |
|
99.57% |
否 |
| HY-N9410S |
Lysophosphatidylcholine 18:2-d9 |
|
≥98.0% |
否 |
| HY-P1793A |
α-Casein (90-95) TFA |
Agonist |
99.58% |
否 |
| HY-P3322 |
Phytochelatin 5 |
|
99.62% |
否 |
| HY-P5272 |
Histatin-3 TFA |
Inhibitor |
99.37% |
否 |
| HY-RS07440 |
KRT17 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
否 |
| HY-W127369 |
1-O-Hexadecyl-2-O-docosahexaenoyl-sn-glycero-3-phosphorylcholine |
|
/ |
否 |
| HY-W127380 |
Arachidonoyl thio-PC |
|
≥98.0% |
否 |
| HY-W440958 |
1-Palmitoyl-2-stearoyl-sn-glycero-3-phosphocholine |
|
99.90% |
否 |
| HY-13626S |
Spisulosine-d3 |
Inducer |
≥99.0% |
否 |
| HY-138622S |
24:0 Lyso PC-13C6 |
|
97.5% |
否 |
| HY-165157 |
1-1(Z)-Hexadecenyl-2-arachidonoyl-sn-glycero-3-PC |
|
≥99.0% |
否 |
| HY-W040193S3 |
1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d83 |
|
/ |
否 |
| HY-W040193S4 |
1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d4 |
|
≥99.0% |
否 |
| HY-W040221 |
Butanoyl PAF |
Agonist |
/ |
否 |
| HY-W190937 |
PC Azido-PEG3-NHS carbonate ester |
|
98.72% |
否 |
| HY-158025 |
Anticancer agent 198 |
Inhibitor |
/ |
否 |
| HY-N11605S |
C16(plasm)-18:1(d9) PC |
|
/ |
否 |
| HY-138633 |
PROTAC BRD4 Degrader-10 |
Inhibitor |
99.75% |
否 |
| HY-138637 |
PROTAC BRD4 Degrader-14 |
Inhibitor |
/ |
否 |
| HY-105118 |
Zaldaride |
Inhibitor |
/ |
否 |
| HY-107640 |
WAY-170523 |
Inhibitor |
/ |
否 |
| HY-11055 |
KP 544 |
|
/ |
否 |
| HY-111266 |
Halenaquinone |
|
/ |
否 |
| HY-111396 |
PC58538 |
Inhibitor |
/ |
否 |
| HY-112661 |
PC-766B |
Inhibitor |
/ |
否 |
| HY-113796 |
Kopsoffinol |
|
/ |
否 |
| HY-115959 |
Anticancer agent 34 |
Inhibitor |
/ |
否 |
| HY-115961 |
Anticancer agent 36 |
Inhibitor |
/ |
否 |
| HY-115974 |
GRPR antagonist-1 |
|
/ |
否 |
| HY-117517 |
NG-012 |
Activator |
/ |
否 |
| HY-118147 |
ML356 |
Inhibitor |
/ |
否 |
| HY-120561 |
PC-046 |
|
/ |
否 |
| HY-120828 |
Albenatide |
Agonist |
/ |
否 |
| HY-121195 |
Apalcillin |
Inhibitor |
/ |
否 |
| HY-121655 |
Dansyllysine |
|
/ |
否 |
| HY-121679 |
COX-2-IN-50 |
Inhibitor |
/ |
否 |
| HY-12364B |
(−)-C75 |
Inhibitor |
/ |
否 |
| HY-123711 |
PC170942 |
Inhibitor |
/ |
否 |
| HY-123715 |
Anticancer agent 255 |
|
/ |
否 |
| HY-124152 |
3,4-Dephostatin |
Inhibitor |
/ |
否 |
| HY-125010 |
Dicycloplatin |
Inducer |
/ |
否 |
| HY-125554 |
KDdiA-PC |
Ligand |
/ |
否 |
| HY-125744 |
Palmitoyl thio-PC |
|
/ |
否 |
| HY-125771S |
1-Stearoyl-sn-glycero-3-phosphocholine-d35 |
|
/ |
否 |
| HY-129449 |
AnnH31 |
Inhibitor |
99.91% |
否 |
| HY-130462S1 |
1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-d82 |
|
/ |
否 |
| HY-133101 |
14-Norpseurotin |
|
/ |
否 |
| HY-133233 |
Thioetheramide-PC |
Inhibitor |
/ |
否 |
| HY-133968S1 |
24-Methylenecholesterol-13C |
|
/ |
否 |
| HY-136480 |
Chrysamine G |
|
/ |
否 |
| HY-137348 |
10-Pyrene-PC |
|
/ |
否 |
| HY-13847 |
GNE-555 |
Inhibitor |
/ |
否 |
| HY-139231 |
1-Palmitoyl-2-formylyl PC |
|
/ |
否 |
| HY-139294 |
PROTAC BRD4 Degrader-15 |
Inhibitor |
/ |
否 |
| HY-140130 |
PC Biotin-PEG3-alkyne |
|
/ |
否 |
| HY-140131 |
Biotin-PEG4-PC-PEG4-alkyne |
|
/ |
否 |
| HY-140133 |
PC-Biotin-PEG4-PEG3-azide |
|
/ |
否 |
| HY-140136 |
PC DBCO-PEG3-biotin |
|
/ |
否 |
| HY-140141 |
PC Methyltetrazine-PEG4-NHS carbonate ester |
|
/ |
否 |
| HY-140863 |
PC-PEG11-Azide |
|
/ |
否 |
| HY-141863 |
Lepidozin G |
Inducer |
/ |
否 |
| HY-142958 |
NF-κB-IN-2 |
|
/ |
否 |
| HY-143445 |
EGFR-IN-48 |
Inhibitor |
/ |
否 |
| HY-143641 |
Anticancer agent 25 |
|
/ |
否 |
| HY-143882 |
MS5033 |
Inhibitor |
/ |
否 |
| HY-143883 |
MS143 |
|
/ |
否 |
| HY-144808 |
Anticancer agent 40 |
Inhibitor |
/ |
否 |
| HY-146038 |
Antitumor agent-55 |
|
/ |
否 |
| HY-146170 |
Anticancer agent 69 |
|
/ |
否 |
| HY-146838S |
17:0-18:1 PC-d5 |
|
/ |
否 |
| HY-146839S |
17:0-16:1 PC-d5 |
|
/ |
否 |
| HY-146841S |
19:0 Lyso PC-d5 |
|
/ |
否 |
| HY-146841S1 |
(Rac)-19:0 Lyso PC-d5 |
|
/ |
否 |
| HY-146848S |
C18(plasm)-18:1 PC-d9 |
|
/ |
否 |
| HY-146849S |
17:0-22:4 PC-d5 |
|
/ |
否 |
| HY-146850S |
17:0-20:3 PC-d5 |
|
/ |
否 |
| HY-146880S |
14:0-14:0 PC-d27 |
|
/ |
否 |
| HY-146891S |
16:0-16:0 PC-d31 |
|
/ |
否 |
| HY-146893S |
18:0-18:0 PC-d35 |
|
/ |
否 |
| HY-146924S |
16:0 (Rac)-PC-d80 |
|
≥99.0% |
否 |
| HY-146925S |
15:0 Lyso PC-d5 |
|
/ |
否 |
| HY-147682 |
NF-κB-IN-5 |
|
/ |
否 |
| HY-147734 |
Calpain Inhibitor-2 |
Inhibitor |
/ |
否 |
| HY-147852 |
B-Raf IN 7 |
Inhibitor |
/ |
否 |
| HY-147853 |
B-Raf IN 8 |
Inhibitor |
/ |
否 |
| HY-147854 |
B-Raf IN 9 |
|
/ |
否 |
| HY-149434 |
PROTAC AR-NTD degrader 1 |
Inducer |
/ |
否 |
| HY-149632 |
EGFR/HER2/DHFR-IN-2 |
Inhibitor |
/ |
否 |
| HY-149729 |
ICMT-IN-53 |
Inhibitor |
/ |
否 |
| HY-149976 |
Pim-1 kinase inhibitor 4 |
Inhibitor |
/ |
否 |
| HY-149995 |
Pim-1 kinase inhibitor 5 |
Inhibitor |
/ |
否 |
| HY-150563 |
Neuroinflammatory-IN-2 |
Inhibitor |
/ |
否 |
| HY-151431 |
Nrf2/HO-1 activator 2 |
|
/ |
否 |
| HY-151940 |
Mal-Pc |
Activator |
/ |
否 |
| HY-153051 |
Antitumor agent-90 |
|
/ |
否 |
| HY-154861 |
Anticancer agent 118 |
|
/ |
否 |
| HY-155049 |
NMDA receptor antagonist 6 |
Antagonist |
/ |
否 |
| HY-155227A |
ALK/EGFR-IN-2 |
Inhibitor |
/ |
否 |
| HY-155227B |
ALK/EGFR-IN-3 |
Inhibitor |
/ |
否 |
| HY-155610 |
VEGFR-2-IN-32 |
Inhibitor |
/ |
否 |
| HY-155718 |
fac-[Re(CO)3(L6)(H2O)][NO3] |
Inducer |
/ |
否 |
| HY-155719 |
fac-[Re(CO)3(L3)(H2O)][NO3] |
Inducer |
/ |
否 |
| HY-157125 |
PI3Kα-IN-14 |
|
/ |
否 |
| HY-157394 |
eeAChE/eqBuChE-IN-1 |
Inhibitor |
/ |
否 |
| HY-157437 |
AChE/BChE-IN-16 |
Inhibitor |
/ |
否 |
| HY-157564 |
Antitumor agent-135 |
Inducer |
/ |
否 |
| HY-157622 |
1-Palmitoyl-2-linoleoyl-sn-glycero-3-phosphocholine |
|
/ |
否 |
| HY-157689 |
1,2-Dieicosenoyl-sn-glycero-3-phosphocholine |
|
/ |
否 |
| HY-157695 |
1-(1Z-Octadecenyl)-2-docosahexaenoyl-sn-glycero-3-phosphocholine |
|
/ |
否 |
| HY-157696 |
18:0 Diether PC |
|
/ |
否 |
| HY-157880 |
N3-PC |
|
/ |
否 |
| HY-158328A |
CA IX/VEGFR-2-IN-2 |
|
/ |
否 |
| HY-158373 |
Anticancer agent 213 |
Inducer |
/ |
否 |
| HY-158710 |
1-Palmitoyl-2-pyropheophorbide a-sn-glycero-3-pc |
|
/ |
否 |
| HY-159149 |
Antitumor agent-182 |
Inducer |
/ |
否 |
| HY-159893 |
SMO-IN-5 |
|
/ |
否 |
| HY-159972 |
PKR1 antagonist 1 |
Antagonist |
/ |
否 |
| HY-160644 |
8PC |
|
/ |
否 |
| HY-161502 |
DHX-SP |
|
/ |
否 |
| HY-161627 |
Anemoside A3-methyl 6-aminohexanoate |
Inhibitor |
/ |
否 |
| HY-161783 |
HDAC6-IN-45 |
|
/ |
否 |
| HY-161785 |
EGFR-IN-117 |
Inhibitor |
/ |
否 |
| HY-161859 |
VEGFR-2/STAT-3-IN-1 |
Inhibitor |
/ |
否 |
| HY-161866 |
EGFR-IN-118 |
Inhibitor |
/ |
否 |
| HY-162304 |
MAGL-IN-14 |
Inhibitor |
/ |
否 |
| HY-162330 |
HDAC6-IN-36 |
Inhibitor |
/ |
否 |
| HY-162380 |
Topoisomerase II inhibitor 18 |
Inhibitor |
/ |
否 |
| HY-162751 |
Anticancer agent 249 |
|
/ |
否 |
| HY-162812 |
H3R antagonist 4 |
Inhibitor |
/ |
否 |
| HY-162885 |
YSY01A |
|
/ |
否 |
| HY-162890 |
EGFR-IN-122 |
Inhibitor |
/ |
否 |
| HY-162891 |
EGFR-IN-123 |
Inhibitor |
/ |
否 |
| HY-162895 |
NL13 |
|
/ |
否 |
| HY-163381 |
Antiproliferative agent-48 |
|
/ |
否 |
| HY-163632 |
EGFR-IN-112 |
Inhibitor |
/ |
否 |
| HY-165030 |
1-Stearoyl-2-15(S)-HETE-sn-glycero-3-PC |
|
/ |
否 |
| HY-165086 |
PON-PC |
|
/ |
否 |
| HY-165097 |
1-Stearoyl-2-15(S)-HpETE-sn-glycero-3-PC |
|
/ |
否 |
| HY-166989 |
1-undecanoyl-2-hydroxy-sn-glycero-3-phosphocholine |
|
/ |
否 |
| HY-167571 |
12:0 Diether PC |
|
/ |
否 |
| HY-167572 |
18:0 (9,10dibromo) PC |
|
/ |
否 |
| HY-167573 |
16:0-10 Doxyl PC |
|
/ |
否 |
| HY-167574 |
16:0-18:0(11-12BR) PC |
|
/ |
否 |
| HY-167816 |
1,2-Diheneicosanoyl-sn-glycero-3-phosphocholine |
Inhibitor |
/ |
否 |
| HY-168068 |
Res-Glu3 |
|
/ |
否 |
| HY-168300 |
Antiangiogenic agent 7 |
|
/ |
否 |
| HY-168371 |
1-Palmitoyl-2-13(S)-HODE-sn-glycero-3-PC |
|
/ |
否 |
| HY-168372 |
1-Myristoyl-2-Linoleoyl-sn-glycero-3-PC |
Ligand |
/ |
否 |
| HY-169006 |
Evo312 |
|
/ |
否 |
| HY-169058 |
GSTP1-1 inhibitor 2 |
Inhibitor |
/ |
否 |
| HY-169078 |
ML234 |
Inhibitor |
/ |
否 |
| HY-169098 |
HSP90/LSD1-IN-1 |
Inhibitor |
/ |
否 |
| HY-169414 |
WRN inhibitor 15 |
|
/ |
否 |
| HY-170221 |
Chol-C10-PC |
|
/ |
否 |
| HY-170386 |
TXY541 |
Inhibitor |
/ |
否 |
| HY-170466 |
16:0-12 Doxyl PC |
|
/ |
否 |
| HY-170933 |
SGK1-IN-6 |
Inhibitor |
/ |
否 |
| HY-172366 |
BQ0413 |
|
/ |
否 |
| HY-172481 |
DSPE-PEG1000-TAASGVRSMH |
|
/ |
否 |
| HY-172482 |
DSPE-PEG2000-TAASGVRSMH |
|
/ |
否 |
| HY-172482A |
DSPE-PEG3400-TAASGVRSMH |
|
/ |
否 |
| HY-172483 |
DSPE-PEG3000-TAASGVRSMH |
|
/ |
否 |
| HY-172562 |
BTR2004 |
Inhibitor |
/ |
否 |
| HY-172872 |
CDK2-IN-45 |
|
/ |
否 |
| HY-172886 |
PI3K-IN-58 |
|
/ |
否 |
| HY-173007 |
ALK/PI3K/AKT-IN-1 |
|
/ |
否 |
| HY-173039 |
α-Tubulin polymerization-IN-1 |
|
/ |
否 |
| HY-173122 |
Akt1-IN-8 |
Inhibitor |
/ |
否 |
| HY-173597 |
ZINC43120769 |
Inhibitor |
/ |
否 |
| HY-17406S |
Tolcapone-d7 |
Inhibitor |
/ |
否 |
| HY-174397 |
EED-IN-3 |
Inhibitor |
/ |
否 |
| HY-175017 |
Survivin-IN-2 |
Inhibitor |
/ |
否 |
| HY-175023 |
OncoACP3 |
|
/ |
否 |
| HY-176284 |
OXPHOS-IN-2 |
|
/ |
否 |
| HY-17638A |
Mizagliflozin (sebacate) |
Inhibitor |
/ |
否 |
| HY-403733C |
JJ-450 |
Antagonist |
/ |
否 |
| HY-B0021S |
Doxifluridine-d2 |
|
/ |
否 |
| HY-B0285AS |
Amiloride-15N3 hydrochloride |
|
/ |
否 |
| HY-B0530A |
Azacyclonol hydrochloride |
|
/ |
否 |
| HY-N10325 |
Sarbronine M |
|
/ |
否 |
| HY-N10384 |
AChE-IN-17 |
Inhibitor |
/ |
否 |
| HY-N10687 |
Saprorthoquinone |
|
/ |
否 |
| HY-N11651 |
Peganumine A |
|
/ |
否 |
| HY-N12004 |
19-Hydroxy-10-deacetylbaccatin III |
|
/ |
否 |
| HY-N12123 |
Peimisine 3-O-β-D-glucopyranoside |
|
/ |
否 |
| HY-N12124 |
Monascuspiloin |
|
/ |
否 |
| HY-N12170 |
Kissoone C |
|
/ |
否 |
| HY-N12225 |
Isoasiaticoside |
|
/ |
否 |
| HY-N12466 |
3′-O-Demethyl-4′-N-demethyl-4′-N-acetyl-4′-epi-staurosporine |
Inhibitor |
/ |
否 |
| HY-N12606 |
Neodidymelliosides A |
Inhibitor |
/ |
否 |
| HY-N12821 |
visamminol-3'-O-glucoside |
|
/ |
否 |
| HY-N13772 |
3'-O-Methyltaxifolin |
Inducer |
/ |
否 |
| HY-N15711 |
Ganoleucoin R |
Inhibitor |
/ |
否 |
| HY-N3489 |
Isodihydrofutoquinol B |
|
/ |
否 |
| HY-N3550 |
Catalponol |
|
/ |
否 |
| HY-N3697 |
Demethoxydeacetoxypseudolaric acid B |
|
99.94% |
否 |
| HY-N3928 |
Garciniaxanthone E |
|
/ |
否 |
| HY-N3938 |
Gelsemiol |
|
/ |
否 |
| HY-N4029 |
Humulene oxide II |
|
/ |
否 |
| HY-N7535 |
Chlorovaltrate K |
|
/ |
否 |
| HY-N8103 |
Heishuixiecaoline A |
|
/ |
否 |
| HY-N9085 |
Neuchromenin |
|
/ |
否 |
| HY-P10786 |
LinTT1 peptide |
Inhibitor |
/ |
否 |
| HY-P1793 |
α-Casein (90-95) |
Agonist |
99.51% |
否 |
| HY-P3321A |
Phytochelatin 4 TFA |
|
/ |
否 |
| HY-P3322A |
Phytochelatin 5 TFA |
|
/ |
否 |
| HY-P3323 |
Phytochelatin 6 |
|
/ |
否 |
| HY-P3323A |
Phytochelatin 6 TFA |
|
/ |
否 |
| HY-P5156 |
BDS-I |
Inhibitor |
/ |
否 |
| HY-P5754 |
TAT-NEP1-40 |
Inhibitor |
/ |
否 |
| HY-P5754A |
TAT-NEP1-40 TFA |
Inhibitor |
/ |
否 |
| HY-P5876 |
Proadrenomedullin (N-20) (bovine, porcine) |
Antagonist |
/ |
否 |
| HY-RS05191 |
G6PC1 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
否 |
| HY-RS05192 |
G6PC2 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
否 |
| HY-RS05193 |
G6PC3 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
否 |
| HY-RS10111 |
PC Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
否 |
| HY-RS10808 |
PODXL Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
否 |
| HY-W019821 |
23:2 Diyne PC [DC(8,9)PC] |
|
/ |
否 |
| HY-W019854 |
14:1 (Δ9-Trans) PC |
|
/ |
否 |
| HY-W040172 |
06:0 Diether PC |
|
/ |
否 |
| HY-W040193S1 |
1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d74 |
|
/ |
否 |
| HY-W040193S2 |
1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d79 |
|
99.3% |
否 |
| HY-W040193S5 |
1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d9 |
|
≥99.0% |
否 |
| HY-W040193S6 |
1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d13 |
|
≥99.0% |
否 |
| HY-W331017 |
1-Hexacosanoyl-sn-glycero-3-phosphocholine |
|
/ |
否 |
| HY-W339358 |
11:0 PC |
|
/ |
否 |
| HY-W340037 |
1,2-Dibutyryl-sn-glycero-3-phosphocholine |
|
/ |
否 |
| HY-W340113 |
15:0 PC |
|
/ |
否 |
| HY-W414749 |
08:0 Lyso PC |
|
/ |
否 |
| HY-W440957 |
PMPC |
|
/ |
否 |
| HY-W590535 |
19:0 PC |
|
/ |
否 |
| HY-W700834 |
Harman-d3 |
|
/ |
否 |
| HY-W713925 |
Diheptanoyl Thio-PC |
|
/ |
否 |
| HY-W725397 |
23:0 PC |
|
/ |
否 |
| HY-W748509 |
Pipernonaline |
|
/ |
否 |
| HY-W777360 |
Harman-13C2,15N |
Inhibitor |
/ |
否 |
| HY-W800732 |
1,2-Dilinoleoyl-sn-glycero-3-PC |
|
/ |
否 |
| HY-W800734 |
1-Myristoyl-2-palmitoyl-sn-glycero-3-phosphocholine |
|
/ |
否 |
| HY-W800785 |
16:0-23:2 Diyne PC |
|
/ |
否 |
| HY-W923483 |
C16-18:1 PC |
|
/ |
否 |
| HY-101392A |
Harmane hydrochloride |
Inhibitor |
/ |
否 |
| HY-115731 |
Tocol |
|
/ |
否 |
| HY-121619 |
Jacaric acid |
Inducer |
/ |
否 |
| HY-122056 |
1,2-Diheptanoyl-SN-glycero-3-phosphocholine |
|
/ |
否 |
| HY-130462S2 |
1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-13C16 |
|
/ |
否 |
| HY-130462S3 |
1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-d64 |
|
/ |
否 |
| HY-134225 |
1-O-Hexadecyl-2-arachidonoyl-sn-glycero-3-PC |
|
/ |
否 |
| HY-137126 |
Photosensitizer Pc 4 |
Inhibitor |
/ |
否 |
| HY-137225 |
HTS07944 |
|
/ |
否 |
| HY-137325A |
2-Chloro-ATP sodium |
|
/ |
否 |
| HY-141636S |
1-PalMitoyl-2-arachidoyllecithin-d9-1 |
|
/ |
否 |
| HY-143857S |
22:0 Lyso PC-13C6 |
|
/ |
否 |
| HY-144086S |
22:0 Lyso-PC-d4 |
|
/ |
否 |
| HY-145547 |
1-Myristoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine |
|
/ |
否 |
| HY-14830 |
SAR 97276 |
Inhibitor |
98.05% |
否 |
| HY-149715 |
R1-11 |
Inhibitor |
/ |
否 |
| HY-157404 |
Pim-1/2 kinase inhibitor 2 |
Inhibitor |
/ |
否 |
| HY-157647 |
1-Stearoyl-2-Adrenoyl-sn-glycero-3-PC |
|
/ |
否 |
| HY-157666 |
13:0 PC |
|
/ |
否 |
| HY-157672 |
18:1-14:0 PC |
|
/ |
否 |
| HY-157675 |
1,2-Dinervonoyl-sn-glycero-3-phosphocholine |
|
/ |
否 |
| HY-159118 |
PC-Qz1 |
Inhibitor |
/ |
否 |
| HY-164283 |
DOCP |
|
/ |
否 |
| HY-164621 |
A3AR antagonist 5 |
Antagonist |
98.17% |
否 |
| HY-165430 |
Antiviral agent 67 |
|
/ |
否 |
| HY-165663S |
1-Myristoyl-d7-2-Linoleoyl-sn-glycero-3-PC |
|
/ |
否 |
| HY-167585S |
16:0-18:2 PC-d5 |
|
/ |
否 |
| HY-167586S |
18:0-22:6 PC-d9 |
|
/ |
否 |
| HY-168373 |
1-Stearoyl-2-Eicosapentaenoyl-sn-glycero-3-PC |
|
/ |
否 |
| HY-168757 |
PSMA precursor-1 |
Ligand |
/ |
否 |
| HY-168796 |
1-Palmitoyl-2-13(S)-HpODE-sn-glycero-3-PC |
|
/ |
否 |
| HY-169476 |
Pyrrolidine linoleamide |
|
/ |
否 |
| HY-169830 |
2-(Cyclohexylmethyl)-plumbagin |
|
/ |
否 |
| HY-176085 |
Heptanoyl thio-PC |
Substrate |
/ |
否 |
| HY-B0285S |
Amiloride-15N3 |
|
/ |
否 |
| HY-N1107 |
Uzarigenin |
|
/ |
否 |
| HY-N12001 |
6-Epiagarotetrol |
|
/ |
否 |
| HY-N14417 |
Indocarbazostatin |
|
/ |
否 |
| HY-N14424 |
Indocarbazostatin B |
|
/ |
否 |
| HY-N3562 |
Cedrin |
Inhibitor |
/ |
否 |
| HY-N3563 |
Celaphanol A |
|
/ |
否 |
| HY-N9257 |
8-Hydroxypinoresinol4,4'-di-O-β-D-glucopyranoside |
|
/ |
否 |
| HY-N9861 |
Kayaflavone |
Inhibitor |
/ |
否 |
| HY-RS16637 |
pc Mouse Pre-designed siRNA Set A |
Pre-designed Set |
/ |
否 |
| HY-RS17167 |
Proc Mouse Pre-designed siRNA Set A |
Pre-designed Set |
/ |
否 |
| HY-RS18605 |
Cbx2 Mouse Pre-designed siRNA Set A |
Pre-designed Set |
/ |
否 |
| HY-RS19229 |
Podxl Mouse Pre-designed siRNA Set A |
Pre-designed Set |
/ |
否 |
| HY-RS20932 |
G6pc3 Mouse Pre-designed siRNA Set A |
Pre-designed Set |
/ |
否 |
| HY-RS23072 |
Pc Rat Pre-designed siRNA Set A |
Pre-designed Set |
/ |
否 |
| HY-RS25718 |
Podxl Rat Pre-designed siRNA Set A |
Pre-designed Set |
/ |
否 |
| HY-RS27449 |
G6pc3 Rat Pre-designed siRNA Set A |
Pre-designed Set |
/ |
否 |
| HY-W275295 |
Perfluorododecanoic acid |
Activator |
/ |
否 |
| HY-W292927 |
(E)-Antiviral agent 67 |
Inhibitor |
/ |
否 |
| HY-W437569 |
Melicopine |
Inhibitor |
/ |
否 |
| HY-W725327 |
1,2-Dipropionyl-sn-glycero-3-phosphocholine |
|
/ |
否 |
| HY-W725399 |
1,2-Dilignoceroyl-sn-glycero-3-phosphocholine |
|
/ |
否 |
| HY-W753474 |
1,2-Dipalmitelaidoyl-sn-glycero-3-phosphocholine |
|
/ |
否 |
| HY-W778562 |
10-Deacetyl-13-oxobaccatin III |
|
/ |
否 |
| HY-W839203 |
22:0 PC |
|
/ |
否 |
| HY-19378 |
MIV-150 |
Inhibitor |
/ |
否 |
